Diversity, Equity, and Inclusion in Clinical Trials

被引：2
|
作者：
Keegan, Grace [1 ]
Crown, Angelena [2 ]
Joseph, Kathie-Ann [3 ,4 ,5 ]
机构：
[1] Keegan Univ Chicago, Pritzker Sch Med, 924 E 57th St, Chicago, IL 60637 USA
[2] Swedish Canc Inst, True Family Womens Canc Ctr, Breast Surg, Seattle, WA USA
[3] NYU, Grossman Sch Med, NYC Hlth & Hosp Bellevue, Dept Surg, New York, NY USA
[4] NYU, Langone Hlth Inst Excellence Hlth Equity, 180 Madison Ave, New York, NY USA
[5] NYU, Grossman Sch Med, Dept Surg, 424 East 34th St, Kimmel Pavil, KP-3 Room 3-102, New York, NY 10016 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 32卷 / 01期
关键词：
Minority groups; Vulnerable populations; Diversity; Equity; Inclusion; Clinical trials; NEGATIVE BREAST-CANCER; OLDER-ADULTS; RACIAL CONCORDANCE; AFRICAN-AMERICANS; PARTICIPATION; RECRUITMENT; RACE; PHYSICIAN; CHEMOTHERAPY; STRATEGIES;
D O I：
10.1016/j.soc.2022.08.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In summary, minority groups are vastly underrepresented in clinical trial participants and leadership. Because these studies provide innovative and revolutionary treatment options to patients with cancer and have the potential to extend survival, it is imperative that public and private stakeholders, as well as hospital and clinical trial leadership, prioritize equity and inclusion of diverse populations in clinical trial development and recruitment strategies. Achieving equity in clinical trials could be an important step in reducing the overall cancer burden and mortality disparities in vulnerable populations.
引用
收藏
页码：221 / 232
页数：12
相关论文
共 50 条
12345